Desirial 1x1 ml

Desirial contains approximately 19 mg/mL of cross-linked hyaluronic acid stabilized using VIVACY’s IPN-Like Technology.
The formulation also includes mannitol, an antioxidant designed to reduce free-radical degradation of HA, support tissue comfort, and extend implant longevity.
The gel is cohesive and optimized specifically for intimate-area hydration, elasticity restoration, and tissue support.

It is appropriate for women experiencing post-menopausal atrophy, postpartum changes, or intimate functional discomfort who desire a minimally invasive injectable solution.

• 1 × 1 ml pre-filled sterile syringe of cross-linked HA gel.

• Hydration, elasticity, and comfort typically last 9–12 months.

Q1: How is Desirial different from regular dermal fillers?
A1: It is engineered specifically for intimate tissue — optimized for hydration, elasticity, and mucosal comfort rather than facial contouring or deep volumizing.

Q2: Is Desirial safe?
A2: Yes, when administered by a licensed medical professional using sterile technique. It is a CE-marked Class III medical device. Mannitol helps reduce inflammation and free-radical degradation.

Q3: When will results appear?
A3: Hydration and comfort often improve immediately after treatment (post-swelling). Full tissue improvement continues over the next several weeks and may last up to a year.

Desirial is manufactured by Laboratoires VIVACY (France), a leading company in hyaluronic-acid and intimate-aesthetic injectables.
Desirial is recognized as one of the first HA injectables dedicated specifically to women’s intimate health and vulvovaginal rejuvenation.